Legionnaires' Disease
Hours: 0.75
Legionnaires' disease gained notoriety in July 1976, when an outbreak of a serious lung infection occurred among those attending the 58th annual convention of the American Legion at the Bellevue-Stratford in Philadelphia. Legionella is widely present in the natural environment, and Legionella pneumophila is well recognized as a common cause of community-acquired pneumonia. In 2008, there were 3,181 cases of Legionnaires' disease reported to the Centers for Disease Control and Prevention. Reports indicate that prevalence of Legionella infections has increased during the past two decades. It is not known if this is due to better diagnostic techniques or changes in the environment.
The goal of this course is to provide nurses, laboratory technologists, and pharmacy technicians with information about Legionnaires’ disease including epidemiology, clinical presentation, diagnosis, and management.
Legionnaires' disease gained notoriety in July 1976, when an outbreak of a serious lung infection occurred among those attending the 58th annual convention of the American Legion at the Bellevue-Stratford in Philadelphia. Legionella is widely present in the natural environment, and Legionella pneumophila is well recognized as a common cause of community-acquired pneumonia. In 2008, there were 3,181 cases of Legionnaires' disease reported to the Centers for Disease Control and Prevention. Reports indicate that prevalence of Legionella infections has increased during the past two decades. It is not known if this is due to better diagnostic techniques or changes in the environment. The goal of this course is to provide nurses, laboratory technologists, and pharmacy technicians with information about Legionnaires’ disease including epidemiology, clinical presentation, diagnosis, and management.
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 0.75 Nursing Contact Hours after successfully completing this course.
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 0.7000 contact hours for participating in this course.
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.75 contact hours for participating in this course.
South Carolina Board of Nursing
South Carolina Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.75 contact hours for participating in this course.
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.75 contact hours for participating in this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 0.75 contact hours for participating in this course.
Accreditation Council for Pharmacy Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Type Activity: [Custom_Code]
Target Audience Designation: [Custom_Code2]
ACPE Universal Activity Number: JA4008266-0000-21-022-H01-T
Florida Board of Pharmacy
Florida Board of Pharmacy (CEBroker Provider #50-290)
This module is approved for 0.75 contact hours.
Kentucky Board of Nursing
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.75 contact hours for participating in this course.
Mississippi Board of Nursing
Mississippi Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.75 contact hours for participating in this course.
North Dakota Board of Nursing
North Dakota Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.75 contact hours for participating in this course.
Tennessee Medical Laboratory Board
Tennessee Medical Laboratory Board (CEBroker Provider #50-290)
Louisiana Board of Medical Examiners- Clinical Laboratory Personnel
Louisiana Board of Medical Examiners - Clinical Laboratory Personnel (CEBroker Provider #50-290)
American Society for Clinical Laboratory Science
Relias LLC is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program.
Describe the characteristics, pathophysiology and epidemiology of Legionella
Discuss treatment options for Legionnaires’ disease
Identify the preferred testing methods for diagnosis
Pharmacy LO: Describe the clinical presentation of Legionella infection
Pharmacy LO: List the risk factors for Legionnaires' disease
Pharmacy LO: Discuss preferred drugs used to treat Legionnaires' disease
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Characteristics
History
Pathophysiology
Epidemiology
Transmission of Legionnaires' Disease
Causes
Patient Presentation and Diagnosis
Laboratory Studies
Treatment
Complications, Morbidity, and Mortality
Prognosis and Prevention
Section 3: Clinical Vignette
ED Diagnosis
Section 4: Conclusion
Summary
Course Contributors
References
Johnny received a B.S. Pharmacy degree from the College of Pharmacy at the Medical University of South Carolina. He has earned certificates in Medication Therapy Management, Injectable Medications, and Asthma Therapy Management. At Relias, Johnny serves as a Partner in Behavioral Health Solutions, where duties include serving on Clinical Analytics and Applications Team, developing algorithms to improve clinical outcomes, engineering clinical consultant, SME, writer, and editor. In addition, he has served on the Executive Board of Directors for CMHCs and other medical organizations, pharmacy manager, APPE Preceptor, and college of pharmacy dean’s advisory council. Disclosure: Johnny J. Bethea, II, RPh discloses the following potential conflict of interests/commercial interests: Relevant Financial Relationship with Relias LLC as a Salaried Employee All of the relationships listed for this individual have been mitigated.Relevant Non-Financial Relationship with No Entities Exists as a Contributor All of the relationships listed for this individual have been mitigated.Subject Matter Expert: Sooa Devereaux, MSN, RN
Instructor: Catherine J. Swift, MT(ASCP)Sooa Devereaux, MSN, RN, has a long history of professional development experience within the hospital setting. She has taught in pre-licensure nursing programs and has mentored many nurses, both new graduate and experienced, throughout her career as a nurse educator. Sooa is a Lead SME Writer at Relias and holds an MSN in Nursing Education.
Disclosure: Sooa Devereaux, MSN, RN has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
Catherine Swift, MT(ASCP) is the clinical laboratory science editor for Relias Learning. She has a Bachelor of Arts in English from Hastings College and a Bachelor of Science in Medical Technology from North Colorado Medical Center. She has experience working in hospital laboratories, clinic laboratories, and research experience in microbiology as well as clinical research trials involving patients and various drug therapies for osteoporosis, endometriosis and bone density at Creighton University School of Medicine. Disclosure: Catherine J. Swift, MT(ASCP) has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
The target audience for this course is: Clinical Laboratory Personnel; Nurses; Pharmacy Technicians; in the following settings: Acute Care Facility.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
